Roles of adenosine A1 and A(2A) receptors in the expression and development of methamphetamine-induced sensitization

Takao Shimazoe, Akiko Yoshimatsu, Atsuko Kawashimo, Shigenori Watanabe

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

We studied the effects of adenosine A1 and A(2A) receptor agonists on the expression and development of methamphetamine-induced sensitization in rats. When animals were treated with the adenosine A1 receptor agonist, N6- cyclohexyladenosine (CHA), along with methamphetamine every 3 days with a total of five administrations, the augmentation of hyperlocomotion by methamphetamine re-administration after 7-day withdrawal (methamphetamine challenge administration) was not inhibited. However, when the adenosine A(2A) receptor agonist, 2-p-(2-carboxyethyl) phenethyl-amino-5'-N- ethylcarboxy-amide adenosine (CGS21680), was administered according to the same schedule, the augmentation was significantly inhibited. On the other hand, when CHA or CGS21680 was administered 30 min before methamphetamine challenge, both drugs dose-dependently inhibited the augmentation of hyperlocomotion. These results suggested that both adenosine A1 and A(2A) receptors play important roles in the expression of methamphetamine-induced sensitization, and that adenosine A(2A) receptors do so in the development of this sensitization.

Original languageEnglish
Pages (from-to)249-254
Number of pages6
JournalEuropean Journal of Pharmacology
Volume388
Issue number3
DOIs
Publication statusPublished - Feb 4 2000

Fingerprint

Adenosine A2A Receptors
Methamphetamine
Adenosine A1 Receptor Agonists
Amides
Adenosine
Appointments and Schedules
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Roles of adenosine A1 and A(2A) receptors in the expression and development of methamphetamine-induced sensitization. / Shimazoe, Takao; Yoshimatsu, Akiko; Kawashimo, Atsuko; Watanabe, Shigenori.

In: European Journal of Pharmacology, Vol. 388, No. 3, 04.02.2000, p. 249-254.

Research output: Contribution to journalArticle

Shimazoe, Takao ; Yoshimatsu, Akiko ; Kawashimo, Atsuko ; Watanabe, Shigenori. / Roles of adenosine A1 and A(2A) receptors in the expression and development of methamphetamine-induced sensitization. In: European Journal of Pharmacology. 2000 ; Vol. 388, No. 3. pp. 249-254.
@article{2ad7a89c88ec4a4886a0654f3eae753c,
title = "Roles of adenosine A1 and A(2A) receptors in the expression and development of methamphetamine-induced sensitization",
abstract = "We studied the effects of adenosine A1 and A(2A) receptor agonists on the expression and development of methamphetamine-induced sensitization in rats. When animals were treated with the adenosine A1 receptor agonist, N6- cyclohexyladenosine (CHA), along with methamphetamine every 3 days with a total of five administrations, the augmentation of hyperlocomotion by methamphetamine re-administration after 7-day withdrawal (methamphetamine challenge administration) was not inhibited. However, when the adenosine A(2A) receptor agonist, 2-p-(2-carboxyethyl) phenethyl-amino-5'-N- ethylcarboxy-amide adenosine (CGS21680), was administered according to the same schedule, the augmentation was significantly inhibited. On the other hand, when CHA or CGS21680 was administered 30 min before methamphetamine challenge, both drugs dose-dependently inhibited the augmentation of hyperlocomotion. These results suggested that both adenosine A1 and A(2A) receptors play important roles in the expression of methamphetamine-induced sensitization, and that adenosine A(2A) receptors do so in the development of this sensitization.",
author = "Takao Shimazoe and Akiko Yoshimatsu and Atsuko Kawashimo and Shigenori Watanabe",
year = "2000",
month = "2",
day = "4",
doi = "10.1016/S0014-2999(99)00899-7",
language = "English",
volume = "388",
pages = "249--254",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Roles of adenosine A1 and A(2A) receptors in the expression and development of methamphetamine-induced sensitization

AU - Shimazoe, Takao

AU - Yoshimatsu, Akiko

AU - Kawashimo, Atsuko

AU - Watanabe, Shigenori

PY - 2000/2/4

Y1 - 2000/2/4

N2 - We studied the effects of adenosine A1 and A(2A) receptor agonists on the expression and development of methamphetamine-induced sensitization in rats. When animals were treated with the adenosine A1 receptor agonist, N6- cyclohexyladenosine (CHA), along with methamphetamine every 3 days with a total of five administrations, the augmentation of hyperlocomotion by methamphetamine re-administration after 7-day withdrawal (methamphetamine challenge administration) was not inhibited. However, when the adenosine A(2A) receptor agonist, 2-p-(2-carboxyethyl) phenethyl-amino-5'-N- ethylcarboxy-amide adenosine (CGS21680), was administered according to the same schedule, the augmentation was significantly inhibited. On the other hand, when CHA or CGS21680 was administered 30 min before methamphetamine challenge, both drugs dose-dependently inhibited the augmentation of hyperlocomotion. These results suggested that both adenosine A1 and A(2A) receptors play important roles in the expression of methamphetamine-induced sensitization, and that adenosine A(2A) receptors do so in the development of this sensitization.

AB - We studied the effects of adenosine A1 and A(2A) receptor agonists on the expression and development of methamphetamine-induced sensitization in rats. When animals were treated with the adenosine A1 receptor agonist, N6- cyclohexyladenosine (CHA), along with methamphetamine every 3 days with a total of five administrations, the augmentation of hyperlocomotion by methamphetamine re-administration after 7-day withdrawal (methamphetamine challenge administration) was not inhibited. However, when the adenosine A(2A) receptor agonist, 2-p-(2-carboxyethyl) phenethyl-amino-5'-N- ethylcarboxy-amide adenosine (CGS21680), was administered according to the same schedule, the augmentation was significantly inhibited. On the other hand, when CHA or CGS21680 was administered 30 min before methamphetamine challenge, both drugs dose-dependently inhibited the augmentation of hyperlocomotion. These results suggested that both adenosine A1 and A(2A) receptors play important roles in the expression of methamphetamine-induced sensitization, and that adenosine A(2A) receptors do so in the development of this sensitization.

UR - http://www.scopus.com/inward/record.url?scp=0033965840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033965840&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(99)00899-7

DO - 10.1016/S0014-2999(99)00899-7

M3 - Article

C2 - 10675733

AN - SCOPUS:0033965840

VL - 388

SP - 249

EP - 254

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -